miR-802-5p是糖尿病病的关键调节剂
Farnoush Kiyanpour1,2, Maryam Abedi3, Yousof Gheisari2
1Department of Bioinformatics, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
概括
在糖尿病病中,MicroRNA-802-5p的调节失调,影响氨酸-血管酶和炎症通路. 这项研究揭示了它在糖尿病病原发生过程中的关键作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 糖尿病病 (DKD) 带来了严重的健康负担,治疗选择有限.
- 了解基因调节网络对于开发有效的DKD疗法至关重要.
- 微RNAs (miRNAs) 是基因网络的关键调节者,而mmu-mir-802-5p以前被确定在糖尿病小鼠脏中失调.
研究的目的:
- 研究微RNA-802-5p (miR-802-5p) 在糖尿病病的发病过程中的作用.
- 为了阐明miR-802-5p在脏组织中的调节功能.
主要方法:
- 使用miRTarBase和TargetScan.p识别了miR-802-5p的目标.
- 进行了基因本体学丰富分析以进行功能推理.
- 通过qPCR和ELISA评估miR-802-5p及其目标 (Pten,Agtr1a) 的表达水平.
主要成果:
- 在糖尿病小鼠的皮和脑髓中,miR-802-5p显著过度表达.
- 功能分析表明miR-802-5p参与氨酸 - 血管新生素通路,炎症和脏发育.
- 观察到Pten转录和Agtr1a蛋白的差异表达.
结论:
- miR-802-5p作为糖尿病病的关键调节剂.
- 微RNA通过氨酸- ангиотензин轴和皮和脑髓中的炎症路径,促进疾病的发病.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
45
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
45
Renal Regulation of Acid-Base Balance
522
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
522
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Acute Kidney Injury V: Interprofessional Care
27
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
27
Renal Failure: Dose Adjustments
123
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
123
Chronic Kidney Disease I: Introduction
42
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
42


